1. The Combat Methamphetamine Epidemic Act of 2005 placed restrictions on all of the following drugs EXCEPT:
A. Phenylpropanolamine
B. Phenylephrine
C. Pseudoephedrine
D. Ephedrine
2. According to the World Drug Report 2013
A. The number of methamphetamine (METH) labs are increasing in the United States
B. The United States and Mexico are responsible for 60% of METH seizures
C. The amount of METH seized globally increased from 51 tons in 2010 to 88 tons in 2011
D. All of the above
3. Methamphetamine enhances the release and synaptic bioavailability of all of the following neurotransmitters EXCEPT:
A. Dopamine
B. Serotonin
C. Galanin
D. Norepinephrine
4. Which of the following statements is NOT correct with regard to methamphetamine:
A. Methamphetamine is lipophilic and readily crosses the blood-brain barrier
B. The sustained release of monoamines from methamphetamine use is largely responsible for its pathology
C. The half-life of methamphetamine is approximately 3 hours
D. Methamphetamine was prescribed to WWII soldiers to help keep them awake
5. Long-term effects of METH abuse that may help pharmacists identify potential users include which of the following:
A. Formication
B. Dyskinesia
C. Poor dental hygiene
D. All of the above
6. An individual consumer may purchase how many grams of pseudoephedrine in a 24-hour period?
A. 9 grams
B. 3.6 grams
C. 7.5 grams
D. 2 grams
7. Which of the following statements is NOT TRUE regarding NPLEx:
A. 24 states are currently enrolled in its tracking system
B. Data logged into its database are not available to all participating states
C. It has helped to reduce the process of smurfing
D. States can enroll and maintain a membership for free
8. With regard to pseudoephedrine laws, which of the following is NOT TRUE:
A. Logbook information must be kept for a minimum of 2 years
B. Logbook information may be kept in written or electronic form
C. Federal law supersedes stricter state legislation
D. Sellers of pseudoephedrine must self-certify to the Attorney General
9. All of the following statements are TRUE regarding phenylephrine EXCEPT:
A. Its oral bioavailability is approximately 38%
B. Its primary mechanism of action is direct stimulation of the α1-adrenergic receptor
C. It's resistant to monoamine oxidase
D. It's available as an intranasal dosage formulation
10. Tarex technology
A. Derails the initial extraction in the METH-making process, which disrupts subsequent steps necessary for production
B. Is only used in over-the-counter (OTC) drug products
C. Is only effective at blocking smokable forms of METH
D. Has not proved to be efficacious in reducing METH extraction using the one-pot method
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Will the information presented cause you to change your practice?
A. Yes
B. No
24. Are you committed to making these changes?
A. Yes
B. No
25. As a result of this activity, did you learn something new?
A. Yes
B. No
26. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology/Specialty Pharmacy
I. Industry/Manufacturing
27. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
